Cartesian Therapeutics
RNAC
RNAC
98 hedge funds and large institutions have $245M invested in Cartesian Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
3% more funds holding
Funds holding: 95 → 98 (+3)
0.04% more ownership
Funds ownership: 1.56% → 1.61% (+0.04%)
Holders
98
Holding in Top 10
2
Calls
$5.25M
Puts
$1.35M
Top Buyers
| 1 | +$6.95M | |
| 2 | +$6.57M | |
| 3 | +$4.49M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.72M |
| 5 |
BlackRock
New York
|
+$3.47M |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$4.19M | |
| 3 | -$3.11M | |
| 4 |
Morgan Stanley
New York
|
-$2.25M |
| 5 |
6CM
683 Capital Management
New York
|
-$2.17M |